Chemical enhancement of cisplatin cytotoxicity in a human ovarian and cervical cancer cell line
Open Access
- 30 September 1990
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 38 (3) , 315-322
- https://doi.org/10.1016/0090-8258(90)90065-s
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Chemical modifiers of cancer treatment.Journal of Clinical Oncology, 1988
- Modification of Radiation Dose-rate Sparing Effects in a Human Carcinoma of the Cervix Cell Line by Inhibitors of DNA RepairInternational Journal of Radiation Biology, 1988
- Cancer chemotherapy: new strategies for success.Journal of Clinical Investigation, 1986
- Karnofsky memorial lecture. The oncologic end game.Journal of Clinical Oncology, 1986
- Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.Journal of Clinical Oncology, 1985
- Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletionBiochemical Pharmacology, 1985
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984
- Analysis of combined drug effects: a new look at a very old problemTrends in Pharmacological Sciences, 1983
- Mice, men, mustards and methylated xanthines: the potential role of caffeine and related drugs in the sensitization of human tumours to alkylating agentsBritish Journal of Cancer, 1981
- Effects of cis-platinum(II) diamminedichloride on survival and the rate of DNA synthesis in synchronously growing HeLa cells in the absence and presence of caffeineChemico-Biological Interactions, 1978